Author | Paul Kelly Marcom, MD | OncLive

Author | Paul Kelly Marcom, MD

Articles

Dr. Marcom on Liquid Biopsies in Breast Cancer

October 11, 2019

Video

Paul Kelly Marcom, MD, discusses the use of liquid biopsies in breast cancer treatment.

Dr. Kelly on the FDA Approval of Ribociclib in HR+ Breast Cancer

March 14, 2017

Video

Paul Kelly Marcom, MD, associate professor of Medicine, Duke University School of Medicine, Duke Cancer Institute, discusses the FDA approval of ribociclib (LEE011) for use in combination with letrozole as a frontline therapy for patients with hormone-receptor (HR)–positive, HER2-negative advanced breast cancer.

Dr. Marcom on Impact of FALCON Trial on HR+ Breast Cancer

November 22, 2016

Video

Paul Kelly Marcom, MD, associate professor of Medicine, Duke University School of Medicine, Duke Cancer Institute, discusses the impact that the FALCON trial findings have had on the field of hormone receptor-positive breast cancer.

Dr. Marcom Reflects on Field of HR+ Breast Cancer

October 22, 2016

Video

Paul Kelly Marcom, MD, associate professor of Medicine, Duke University School of Medicine, Duke Cancer Institute, discusses how the field of hormone receptor (HR)-positive breast cancer has evolved.

x